本页面由Tiger Trade Technology Pte. Ltd.提供服务

Acurx Pharmaceuticals, LLC*

1.28
+0.01000.79%
盘后:1.280.0006+0.05%19:30 EDT
成交量:8.08万
成交额:10.31万
市值:700.33万
市盈率:-0.42
高:1.30
开:1.28
低:1.25
收:1.27
52周最高:7.98
52周最低:1.23
股本:547.13万
流通股本:534.27万
量比:1.16
换手率:1.51%
股息:- -
股息率:- -
每股收益(TTM):-3.0454
每股收益(LYR):-5.3153
净资产收益率:-128.11%
总资产收益率:-55.92%
市净率:0.86
市盈率(LYR):-0.24

数据加载中...

2022/05/11

重要事件披露

8-K - Current report
2022/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/17

重要事件披露

8-K - Current report
2022/03/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/16

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/11/24

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/22

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/22

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/10

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/19

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/06

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/07/06

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/29

重要事件披露

8-K - Current report
2021/06/22

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/22

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/11

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/06/11

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/27

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/05/26

SEC问询函

CORRESP [Cover] - Correspondence